Keun Ok An1, Junghoon Kim2. 1. Sports and Health Care Major, College of Humanities and Arts, Korea National University of Transportation, Chungju, Chungbuk, Republic of Korea. 2. Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Republic of Korea. Electronic address: junghoonkim@gachon.ac.kr.
Abstract
OBJECTIVES: Age-related muscle loss (sarcopenia) and increased fat mass (obesity) may contribute to chronic disease. Multimorbidity needs more complex health care and is associated with an elevated risk of mortality, disability, and poor quality of life. Sarcopenia and obesity together may be more closely associated with multimorbidity than either sarcopenia or obesity alone. However, a possible multimorbidity link with sarcopenic obesity is unknown. Thus, we aimed to investigate the association of sarcopenic obesity and multimorbidity in Korean adults. DESIGN/ SETTING: A nationwide cross-sectional study based on data from Korea National Health and Nutritional Examination Survey, 2008 to 2011. PARTICIPANTS: Study participants included 10,118 adults aged ≥40 years. MEASUREMENTS: Skeletal muscle mass was measured using dual energy x-ray absorptiometry. Sarcopenia was defined as 1 standard deviation below the mean using the skeletal muscle mass index based on a young population reference group. Obesity was defined using the waist circumference sex-specific cutoff point for Asians. RESULTS: When examined individually, there was a significant association of sarcopenia [odds ratio (OR): 1.49, 95% confidence interval (CI): 1.31-1.70] and obesity (OR: 1.63, 95% CI: 1.45-1.84) with the risk of multimorbidity after being adjusted for potential covariates. When examined as sarcopenia and obesity combined, a greater increase in the risk of multimorbidity was found (OR: 3.0, 95% CI: 2.60-3.40) compared with either sarcopenia (OR: 1.50, 95% CI: 1.18-1.77) or obesity (OR: 1.80, 95% CI: 1.39-2.30) alone. CONCLUSIONS: In conclusion, we found that sarcopenia and obesity are independently associated with the risk of multimorbidity, but with these conditions combined, sarcopenic obesity has a greater risk of multimorbidity.
OBJECTIVES: Age-related muscle loss (sarcopenia) and increased fat mass (obesity) may contribute to chronic disease. Multimorbidity needs more complex health care and is associated with an elevated risk of mortality, disability, and poor quality of life. Sarcopenia and obesity together may be more closely associated with multimorbidity than either sarcopenia or obesity alone. However, a possible multimorbidity link with sarcopenic obesity is unknown. Thus, we aimed to investigate the association of sarcopenic obesity and multimorbidity in Korean adults. DESIGN/ SETTING: A nationwide cross-sectional study based on data from Korea National Health and Nutritional Examination Survey, 2008 to 2011. PARTICIPANTS: Study participants included 10,118 adults aged ≥40 years. MEASUREMENTS: Skeletal muscle mass was measured using dual energy x-ray absorptiometry. Sarcopenia was defined as 1 standard deviation below the mean using the skeletal muscle mass index based on a young population reference group. Obesity was defined using the waist circumference sex-specific cutoff point for Asians. RESULTS: When examined individually, there was a significant association of sarcopenia [odds ratio (OR): 1.49, 95% confidence interval (CI): 1.31-1.70] and obesity (OR: 1.63, 95% CI: 1.45-1.84) with the risk of multimorbidity after being adjusted for potential covariates. When examined as sarcopenia and obesity combined, a greater increase in the risk of multimorbidity was found (OR: 3.0, 95% CI: 2.60-3.40) compared with either sarcopenia (OR: 1.50, 95% CI: 1.18-1.77) or obesity (OR: 1.80, 95% CI: 1.39-2.30) alone. CONCLUSIONS: In conclusion, we found that sarcopenia and obesity are independently associated with the risk of multimorbidity, but with these conditions combined, sarcopenic obesity has a greater risk of multimorbidity.
Authors: Lorenzo M Donini; Luca Busetto; Stephan C Bischoff; Tommy Cederholm; Maria D Ballesteros-Pomar; John A Batsis; Juergen M Bauer; Yves Boirie; Alfonso J Cruz-Jentoft; Dror Dicker; Stefano Frara; Gema Frühbeck; Laurence Genton; Yftach Gepner; Andrea Giustina; Maria Cristina Gonzalez; Ho-Seong Han; Steven B Heymsfield; Takashi Higashiguchi; Alessandro Laviano; Andrea Lenzi; Ibolya Nyulasi; Edda Parrinello; Eleonora Poggiogalle; Carla M Prado; Javier Salvador; Yves Rolland; Ferruccio Santini; Mireille J Serlie; Hanping Shi; Cornel C Sieber; Mario Siervo; Roberto Vettor; Dennis T Villareal; Dorothee Volkert; Jianchun Yu; Mauro Zamboni; Rocco Barazzoni Journal: Obes Facts Date: 2022-02-23 Impact factor: 4.807
Authors: Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield Journal: Ann Med Date: 2018-09-12 Impact factor: 4.709
Authors: Zeynel Abidin Abidin Öztürk; İbrahim Halil Türkbeyler; Zeynep Demir; Muhammet Bilici; Yalçın Kepekçi Journal: Turk J Phys Med Rehabil Date: 2017-11-14
Authors: Davy Vancampfort; Lee Smith; Brendon Stubbs; Nathalie Swinnen; Joseph Firth; Felipe B Schuch; Ai Koyanagi Journal: PLoS One Date: 2018-08-30 Impact factor: 3.240